Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has been demonstrated to be able to activate complement, making patients with deficiency in negative complement regulation, such as paroxysmal nocturnal hemoglobinuria (PNH), part...
Saved in:
| Main Authors: | Steve Biko Otieno, Alaa Altahan, Fnu Kaweeta, Saradasri Karri, Fnu Alnoor, Robert Johnson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2021/6619177 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
by: Cameron Perry, et al.
Published: (2025-06-01) -
Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program
by: Hayeong Rho, et al.
Published: (2025-07-01) -
Crovalimab: A Novel Approach in the Management of Paroxysmal Nocturnal Hemoglobinuria
by: Laiba Jalal, et al.
Published: (2025-07-01) -
Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
by: Ting Wu, et al.
Published: (2025-08-01) -
Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
by: A. Amendola, et al.
Published: (2021-04-01)